Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1915.0,1.0,Δ246-252,241,Δ246-252,1,=,2099.0,1.0,=,0.9
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1170.0,1.0,Δ246-252,241,Δ246-252,1,=,905.0,1.0,=,1.3
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,672.0,1.0,Δ246-252,241,Δ246-252,1,=,679.0,1.0,=,1.0
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,571.0,1.0,Δ246-252,241,Δ246-252,1,=,752.0,1.0,=,0.8
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3338.0,1.0,Δ246-252,241,Δ246-252,1,=,2916.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3486.0,1.0,Δ246-252,241,Δ246-252,1,=,2678.0,1.0,=,1.3
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2294.0,1.0,Δ246-252,241,Δ246-252,1,=,2159.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,697.0,1.0,Δ246-252,241,Δ246-252,1,=,584.0,1.0,=,1.2
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2572.0,1.0,Δ246-252,241,Δ246-252,1,=,2505.0,1.0,=,1.0
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,939.0,1.0,Δ246-252,241,Δ246-252,1,=,1050.0,1.0,=,0.9
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1445.0,1.0,Δ246-252,241,Δ246-252,1,=,987.0,1.0,=,1.5
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2205.0,1.0,Δ246-252,241,Δ246-252,1,=,2015.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1689.0,1.0,Δ246-252,241,Δ246-252,1,=,1500.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3189.0,1.0,Δ246-252,241,Δ246-252,1,=,2949.0,1.0,=,1.1
Tada21e,10.3389/fimmu.2022.797589,Pseudovirus (HIV),Supplementary Figure S1B,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1352.0,1.0,Δ246-252,241,Δ246-252,1,=,1112.0,1.0,=,1.2